Navigation Links
$685,000 too much for construction Web site, critics say

data.

Manthey said that he thinks the site has proved its worth to users. In November it had around 31,000 unique visitors, he said. Significant events such as a bridge demolition on December 10 have pushed the number of daily hits past 200,000.

He also said connections from all 50 states had been logged.

To people who use the Interchange less frequently this site gives......

Full article >>>
'"/>

Source:wistechnology.com By Les Chappell 12/15/04


Page: 1 2 3

Related biology technology :

1. The deconstruction of Big Pharma
2. Polar neutrino observatory construction leaps ahead
3. Epic responds to critics of electronic record installation
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: too much for construction Web site critics say

Breaking Biology Technology:New technology could boost disease detection tests' speed and sensitivity 2Myriant Technologies LLC Selected for $50 Million Award for Succinic Acid Biorefinery Project 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6EUCODIS Bioscience Appoints Thomas Fischer as New CEO 2